Bone Density Loss: Tenofovir has been affiliated with a minimize in bone mineral density, increasing the potential risk of bone difficulties or fractures. HIV-one contaminated topics on dolutegravir monotherapy demonstrated rapid and dose-dependent reduction of antiviral exercise with declines of HIV-1 RNA copies for each ml. The antiviral reaction was https://hivhub.in/product/viropil-tablet/